Addition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks

Kuhadiya, Nitesh D., Dhindsa, Sandeep, Ghanim, Husam, Mehta, Aditya, Makdissi, Antoine, Batra, Manav, Sandhu, Sartaj, Hejna, Jeanne, Green, Kelly, Bellini, Natalie, Yang, Min, Chaudhuri, Ajay, Dandona, Paresh·2016·Diabetes Care
DOI 10.2337/dc15-1136

Cited by (101)

Items 101–101 of 101

  1. Combination of Glucagon-like Peptide-1 Receptor Agonists and Sodium–Glucose Cotransporter Inhibitors in Type 1 Diabetes: Why, when and How? An Exploration of the Rationale and Clinical Scenarios for Combining These 2 Adjunctive Agents
    Husam Ghanim, Sambasiva Rao Srungavarapu, Paresh Dandona, Ajay Chaudhuri · 2026 · Endocrinology and Metabolism Clinics of North America